首页|First Affiliated Hospital of Fujian Medical University Reports Findings in Perso nalized Medicine (Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel ...)
First Affiliated Hospital of Fujian Medical University Reports Findings in Perso nalized Medicine (Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel ...)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news reporting or iginating from Fuzhou, People’s Republic of China, by NewsRx correspondents, res earch stated, “Precise evaluation of pathological complete response (pCR) is ess ential for determining the prognosis of patients with locally advanced rectal ca ncer (LARC) undergoing neoadjuvant chemoradiotherapy (NCRT) and can offer clues for the selection of subsequent treatment strategies. Most current predictive mo dels for pCR focus primarily on pre-treatment factors, neglecting the dynamic sy stemic changes that occur during neoadjuvant chemoradiotherapy, and are constrai ned by low accuracy and lack of integrity.”
FuzhouPeople’s Republic of ChinaAsiaCancerCyborgsDrugs and TherapiesEmerging TechnologiesGastroenterologyHealth and MedicineMachine LearningOncologyPersonalized MedicinePersona lized TherapyRectal CancerRisk and PreventionSurgery
NETL
NSTL
